Partners Capital Investment Group’s United Therapeutics UTHR Stock Holding History

Partners Capital Investment Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Sell	3,120 -531	-15%	-$299K	0.06%	98
2026 Q1	$2.16M	Sell	3,651 -425	-10%	-$212K	0.08%	86
2025 Q4	$1.99M	Sell	4,076 -1,763	-30%	-$821K	0.07%	90
2025 Q3	$2.45M	Hold	5,839	–	–	0.1%	92
2025 Q2	$1.68M	Sell	5,839 -520	-8%	-$155K	0.07%	97
2025 Q1	$1.96M	Buy	+6,359	New	+$2.18M	0.03%	122
2024 Q4	–	Sell	-7,937	Closed	-$2.84M	–	164
2024 Q3	$2.84M	Sell	7,937 -962	-11%	-$325K	0.05%	114
2024 Q2	$2.83M	Buy	+8,899	New	+$2.36M	0.05%	118
2024 Q1	–	Sell	-11,013	Closed	-$2.42M	–	263
2023 Q4	$2.42M	Buy	11,013 +304	+3%	+$70.1K	0.05%	119
2023 Q3	$2.42M	Sell	10,709 -828	-7%	-$191K	0.06%	113
2023 Q2	$2.55M	Sell	11,537 -1,601	-12%	-$355K	0.05%	120
2023 Q1	$2.94M	Sell	13,138 -14,034	-52%	-$3.46M	0.13%	87
2022 Q4	$7.56M	Buy	27,172 +11,043	+68%	+$2.79M	0.36%	54
2022 Q3	$3.38M	Buy	+16,129	New	+$3.61M	0.2%	72

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Partners Capital Investment Group's UTHR Position: Q2 2026 in Review

Partners Capital Investment Group reduced its United Therapeutics (UTHR) stake by 15% in Q2 2026, selling an estimated $299K and leaving 3,120 shares worth $1.69M. The position accounts for 0.06% of the portfolio, ranked #98.

Partners Capital Investment Group first reported a position in UTHR in Q3 2022 and has held it in 14 quarters since. The position peaked at $7.56M in Q4 2022. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Partners Capital Investment Group held 3,120 shares of United Therapeutics worth $1.69M as of Q2 2026.
Partners Capital Investment Group sold 531 United Therapeutics shares in Q2 2026, an estimated $299K.
United Therapeutics made up 0.06% of Partners Capital Investment Group's portfolio in Q2 2026, its #98 holding.
Partners Capital Investment Group first reported a position in United Therapeutics in Q3 2022 and has held it in 14 quarters since.
Partners Capital Investment Group's United Therapeutics position peaked at $7.56M in Q4 2022.
884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Partners Capital Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.